Ascentage Pharma
AAPG
11.97
-0.47
-3.78%
Ascentage Pharma
US · AAPG
#3045 by market cap
Listed 2025
11.97
-0.47
-3.78%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
D
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 7 analysts
Buy
Avg price target 42.00 +250.9%
Price target rangecurrent 11.97
Low33.00
Avg42.00
High48.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-05 | BTIG | -- | Buy | 48.00 |
| 2026-10-15 | Citi | -- | Buy | 46.00 |
| 2026-10-14 | Citi | -- | Buy | 46.00 |
| 2026-10-13 | Citizens JMP | -- | Buy | 35.00 |
| 2026-10-08 | J.P. Morgan | -- | Buy | 33.00 |
| 2026-09-02 | B. Riley Securities | -- | Buy | 45.00 |
| 2026-08-21 | Truist Financial | -- | Buy | -- |
| 2026-08-21 | Oppenheimer | -- | Buy | 45.00 |
| 2026-08-20 | BTIG | -- | Buy | 48.00 |
| 2026-08-10 | Truist Financial | -- | Buy | -- |
| 2026-06-15 | Oppenheimer | -- | Buy | 45.00 |
| 2026-06-10 | B. Riley Securities | -- | Buy | 45.00 |
| 2026-06-01 | Piper Sandler | -- | Buy | 48.00 |
| 2026-05-13 | BTIG | -- | Buy | 48.00 |
| 2026-04-24 | Truist Financial | -- | Buy | 51.00 |
| 2026-04-22 | Piper Sandler | -- | Buy | 48.00 |
| 2026-04-15 | Piper Sandler | -- | Buy | 48.00 |
| 2026-04-15 | J.P. Morgan | -- | Buy | 46.00 |
| 2026-04-13 | BTIG | -- | Buy | 48.00 |
| 2026-04-10 | Piper Sandler | -- | Buy | 48.00 |
| 2026-03-27 | Truist Financial | -- | Buy | 51.00 |
| 2026-03-26 | BTIG | -- | Buy | 48.00 |
| 2026-03-12 | BTIG | -- | Buy | 48.00 |
| 2026-03-11 | BTIG | -- | Buy | 48.00 |
| 2026-01-08 | Piper Sandler | -- | Buy | 48.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Actual move |
|---|---|---|---|
| 2026/Q2 | 2026-08-19 | -- | -0.93% |
| 2025/Q4 | 2026-03-25 | After close | -4.84% |
| 2025/Q2 | 2025-08-20 | After close | +1.05% |
| 2024/Q4 | 2025-03-27 | -- | +9.96% |
Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.
Ascentage Pharma discussion 0 comments